These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24466274)

  • 41. MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2.
    Shao Y; Li P; Zhu ST; Yue JP; Ji XJ; Ma D; Wang L; Wang YJ; Zong Y; Wu YD; Zhang ST
    Oncotarget; 2016 Mar; 7(12):15173-86. PubMed ID: 26959737
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3.
    Teng Y; Zhang Y; Qu K; Yang X; Fu J; Chen W; Li X
    Oncotarget; 2015 Dec; 6(38):40799-814. PubMed ID: 26512921
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HOTAIRM1 suppresses cell proliferation and invasion in ovarian cancer through facilitating ARHGAP24 expression by sponging miR-106a-5p.
    Chao H; Zhang M; Hou H; Zhang Z; Li N
    Life Sci; 2020 Feb; 243():117296. PubMed ID: 31935390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MiR-760 overexpression promotes proliferation in ovarian cancer by downregulation of PHLPP2 expression.
    Liao Y; Deng Y; Liu J; Ye Z; You Z; Yao S; He S
    Gynecol Oncol; 2016 Dec; 143(3):655-663. PubMed ID: 27726922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin.
    Zhang J; Han C; Wu T
    Gastroenterology; 2012 Jul; 143(1):246-56.e8. PubMed ID: 22484120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Upregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progression.
    Li J; Hu K; Gong G; Zhu D; Wang Y; Liu H; Wu X
    Sci Rep; 2017 Feb; 7():41330. PubMed ID: 28145479
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression.
    Zhang J; Liu L; Sun Y; Xiang J; Zhou D; Wang L; Xu H; Yang X; Du N; Zhang M; Yan Q; Xi X
    Oncotarget; 2016 May; 7(18):26516-34. PubMed ID: 27049921
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
    Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
    Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced phosphorylation of p53 by microRNA-26a leading to growth inhibition of pancreatic cancer.
    Batchu RB; Gruzdyn OV; Qazi AM; Kaur J; Mahmud EM; Weaver DW; Gruber SA
    Surgery; 2015 Oct; 158(4):981-6; discussion 986-7. PubMed ID: 26189069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-340 Induces Apoptosis and Inhibits Metastasis of Ovarian Cancer Cells by Inactivation of NF-x03BA;B1.
    Li P; Sun Y; Liu Q
    Cell Physiol Biochem; 2016; 38(5):1915-27. PubMed ID: 27160777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer.
    Li Y; Sun Z; Liu B; Shan Y; Zhao L; Jia L
    Cell Death Dis; 2017 Jun; 8(6):e2892. PubMed ID: 28640257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer.
    Zhang Y; Zhao FJ; Chen LL; Wang LQ; Nephew KP; Wu YL; Zhang S
    Oncotarget; 2014 Dec; 5(23):12291-303. PubMed ID: 25460499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MiR-543 functions as tumor suppressor in ovarian cancer by targeting TWIST1.
    Yu Q; Zhang Z; He B; Wang H; Shi P; Li Y
    J Biol Regul Homeost Agents; 2020; 34(1):101-110. PubMed ID: 32148011
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MiR-574-3p exerts as a tumor suppressor in ovarian cancer through inhibiting MMP3 expression.
    Zheng J; Zhou Y; Li XJ; Hu JM
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6839-6848. PubMed ID: 31486483
    [TBL] [Abstract][Full Text] [Related]  

  • 55. miR-137 suppresses cell growth in ovarian cancer by targeting AEG-1.
    Guo J; Xia B; Meng F; Lou G
    Biochem Biophys Res Commun; 2013 Nov; 441(2):357-63. PubMed ID: 24144591
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long non-coding RNA EPB41L4A-AS2 suppresses progression of ovarian cancer by sequestering microRNA-103a to upregulate transcription factor RUNX1T1.
    Sun T; Yang P; Gao Y
    Exp Physiol; 2020 Jan; 105(1):75-87. PubMed ID: 31645082
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LINC00657/miR-26a-5p/CKS2 ceRNA network promotes the growth of esophageal cancer cells via the MDM2/p53/Bcl2/Bax pathway.
    Zhang XM; Wang J; Liu ZL; Liu H; Cheng YF; Wang T
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32426838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Down-regulated miR-26a promotes proliferation, migration, and invasion
    Yang C; Zheng S; Liu T; Liu Q; Dai F; Zhou J; Chen Y; Sheyhidin I; Lu X
    FASEB J; 2017 May; 31(5):2114-2122. PubMed ID: 28174206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-26a/b Inhibit Tumor Growth and Angiogenesis by Targeting the HGF-VEGF Axis in Gastric Carcinoma.
    Si Y; Zhang H; Ning T; Bai M; Wang Y; Yang H; Wang X; Li J; Ying G; Ba Y
    Cell Physiol Biochem; 2017; 42(4):1670-1683. PubMed ID: 28738343
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer.
    Peng DX; Luo M; Qiu LW; He YL; Wang XF
    Oncol Rep; 2012 Apr; 27(4):1238-44. PubMed ID: 22246341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.